Anixa Biosciences advances CAR T-cell therapy for recurrent ovarian cancer, targeting FSHR with promising safety and efficacy ...

After a single dose of equecabtagene autoleucel, three people with progressive MS saw benefits, including improved walking ...

Governor Greg Abbott has signed House Bill 3057 into law. The bill, authored by State Representative Brooks Landgraf, is set ...

TG Therapeutics, Inc.'s BRIUMVI saw Q1 2025 revenue surge 137% YoY. Click to learn about TGTX growth, upcoming trials, and ...

While presenting the data at this year's American Society of Clinical Oncology (ASCO) annual meeting, Peter Voorhees, MD, of ...

Researchers sought to determine whether CAR-T therapy could improve HR-QoL scores for patients with relapsed or refractory multiple myeloma.

Modern DNA synthesis platforms empower researchers to explore the molecular world, from next-generation sequencing to cell ...

Although the mother and her breastmilk tested positive for CAR T cells, the baby did not, showing only normal T- and B-cell subsets.

Xcell Biosciences, an instrumentation company focused on cell and gene therapy applications, has partnered with Thermo Fisher ...

The blood cancer multiple myeloma is deadly. This disease is personal for us because one of our best friends and colleagues ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.